Search Count: 20
 |
Human Aldose Reductase Mutant A299G/L300A In Complex With A Ligand With An Idd Structure (3-({[2-(Carboxymethoxy)-4-Fluorobenzoyl]Amino}Methyl)Benzoic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2024-06-12 Classification: OXIDOREDUCTASE Ligands: NAP, CIT, 4G7 |
 |
Human Aldose Reductase Mutant A299G/L300A In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.04 Å Release Date: 2024-05-15 Classification: OXIDOREDUCTASE Ligands: NAP, 30L, CIT |
 |
Human Aldose Reductase Mutant L300G In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.95 Å Release Date: 2024-03-06 Classification: OXIDOREDUCTASE Ligands: NAP, 30L, CIT |
 |
Human Aldose Reductase Mutant L300G In Complex With A Ligand With An Idd Structure (3-({[2-(Carboxymethoxy)-4-Fluorobenzoyl]Amino}Methyl)Benzoic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.94 Å Release Date: 2024-03-06 Classification: OXIDOREDUCTASE Ligands: NAP, 4G7, CIT |
 |
Human Aldose Reductase Mutant A299G/L300G In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.96 Å Release Date: 2023-09-27 Classification: OXIDOREDUCTASE Ligands: NAP, 30L, CIT |
 |
Human Aldose Reductase Mutant A299G In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.95 Å Release Date: 2023-09-06 Classification: OXIDOREDUCTASE Ligands: NAP, 30L, CIT |
 |
Human Aldose Reductase Mutant L300/301A In Complex With A Ligand With An Idd Structure (3-({[2-(Carboxymethoxy)-4-Fluorobenzoyl]Amino}Methyl)Benzoic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.94 Å Release Date: 2021-02-24 Classification: OXIDOREDUCTASE Ligands: 4G7, CIT, NAP |
 |
Human Aldose Reductase Mutant L300/301A In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.97 Å Release Date: 2021-02-03 Classification: OXIDOREDUCTASE Ligands: 30L, CIT, NAP |
 |
Human Aldose Reductase Mutant L300A In Complex With A Ligand With An Idd Structure (3-({[2-(Carboxymethoxy)-4-Fluorobenzoyl]Amino}Methyl)Benzoic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.95 Å Release Date: 2021-01-27 Classification: OXIDOREDUCTASE Ligands: CIT, 4G7, 2WR, NAP |
 |
Human Aldose Reductase Mutant L300A In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.97 Å Release Date: 2020-11-18 Classification: OXIDOREDUCTASE Ligands: NAP, 30L, CIT |
 |
Human Aldose Reductase Mutant L301A In Complex With A Ligand With An Idd Structure (3-({[2-(Carboxymethoxy)-4-Fluorobenzoyl]Amino}Methyl)Benzoic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.01 Å Release Date: 2020-11-18 Classification: OXIDOREDUCTASE Ligands: 4G7, CIT, NAP |
 |
Human Aldose Reductase Mutant L301A In Complex With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.97 Å Release Date: 2020-11-18 Classification: OXIDOREDUCTASE Ligands: 30L, CIT, NAP |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.93 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: NAP, CIT, M0K |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure (2) At 1.07 A.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.07 Å Release Date: 2016-03-23 Classification: OXIDOREDUCTASE Ligands: NAP, 4G7 |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure At 1.20 A (1)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2015-11-18 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: 3UH, NAP |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure (2-[2-(1,3-Benzothiazol-2-Ylmethylcarbamoyl)-5-Fluoro-Phenoxy]Acetic Acid) At 1.05 A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.05 Å Release Date: 2015-08-12 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NAP, 37V |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure ({5-Fluoro-2-[(3-Nitrobenzyl)Carbamoyl]Phenoxy}Acetic Acid) At 0.98 A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:0.98 Å Release Date: 2015-07-22 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NAP, 30L, CIT |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure ([2-(Benzylcarbamoyl)-5-Fluorophenoxy]Acetic Acid) At 1.19 A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.19 Å Release Date: 2015-06-10 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NAP, 2YZ |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure (2-(2-Carbamoyl-5-Fluoro-Phenoxy)Acetic Acid) At 1.14 A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.14 Å Release Date: 2015-04-08 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: NAP, 2WR |
 |
Human Aldose Reductase Complexed With A Ligand With An Idd Structure (2-[5-Fluoro-2-(Prop-2-Ynylcarbamoyl)Phenoxy]Acetic Acid) At 1.12 A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2015-04-08 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: 2WQ, CIT, NAP |